DOCSLIB.ORG

Information for Institutions Contents

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
Information for Institutions Contents Publications Information for Institutions Contents JAMA Introduction 3 JAMA 4 JAMA Network Specialty Journals 5 JAMA Oncology 8 JAMA Network Online Features 9 The JAMA Network Mobile 10 The JAMA Network Backfiles 11 Pricing JAMA Network Site Licenses 13 2016 Site License Pricing 14 JAMA Network Backfiles Pricing 16 2016 Institutional Print Pricing 18 Back Issues 19 jamanetwork.org Building on a tradition of editorial excellence, The JAMA Network brings JAMA together with an array of specialty journals to offer enhanced access to the research, reviews, and Viewpoints shaping the future of medicine. Through a variety of innovative tools, The JAMA Network provides the insights that matter most to medical research and practice. PRINT JOURNALS From JAMA Dermatology to JAMA Surgery, JAMA Network journals are the authoritative source for cutting-edge research and thought-provoking Viewpoints across medical specialties. WEBSITE JAMANetwork.com connects you with information on the topics that interest you, revealing related articles from across the network on every page. Features include video, audio, CME quizzes, and more. An innova- tive search engine that targets concepts as opposed to key words makes finding and filtering information faster and more efficient. MOBILE Read content from The JAMA Network anytime, on any device. All JAMA Network websites are mobile-optimized for a pleasant reading experience on your smartphone or tablet. Site-license subscriptions also include full-text access to The JAMA Network Reader, a web app that displays the latest issues, articles, and features on a desktop, laptop, tablet, or smartphone—and allows you to download content for offline reading. Institutions that have a site license to one or more JAMA Network journals may provide patrons with a full year of access via the Reader. The Journal of the American Medical Association jama.com Since 1883, physicians and health care professionals peer-reviewed general medical journals in the world, JAMA around the world have turned to JAMA for ground-breaking provides readers throughout the world with essential research and insightful commentary from leaders in medicine medical information and a unique forum for discussions and health care. As one of the most widely circulated shaping the future of medical practice and public health. FEATURES INCLUDE: Original Research JAMA Clinical Guidelines Synopsis Online Features at jama.com Reports of authoritative, cutting-edge, Concise summaries of guidelines • Weekly CME quizzes that offer AMA and practice-changing research. recommendations in a format designed PRA Category 1 Credit™ for busy physicians. • PDF article downloads Viewpoints • Email alerts Timely opinions of leading scholars Clinical Reviews and Education on a diverse range of contemporary Timely, evidence-based reviews • Topic collections that span The JAMA medical issues. providing clinically useful therapeutic Network and diagnostic insight. • Relevant links to PubMed and other The JAMA Clinical Challenge resources Assess a patient case, study the image(s), JAMA Patient Page • Weekly podcasts and take a quiz to see if you’ve chosen the Key facts presented in patient-friendly • PowerPoint image downloads best course of action. terms with links to resources on a wide variety of health topics. Author Video Interviews Listen to the author discuss the study to JAMA Guide to Statistics and Methods gain a deeper understanding of a study’s Clear explanations of the statistical objectives, findings, and implications. approaches and research methodology used in individual articles. Editor: Howard Bauchner, MD 2014 Impact Factor: 35.289 Frequency: (Weekly) 48 issues per year Print ISSN: 0098-7484 Online ISSN: 1538-3598 Published Since: 1883 2016 Volume Number: 315–316 COUNTER-Compliant Usage Statistics: Yes Athens/Shibboleth Authentication: Available JAMA NETWORK SPECIALTY JOURNALS Editor: June K. Robinson, MD Editor: John S. Rhee, MD, MPH Editor: Rita F. Redberg, MD, MSc Print Frequency: 12 issues per year Print Frequency: 6 issues per year Print Frequency: 12 issues per year Print ISSN: 0003-987X Print ISSN: 1521-2491 Print ISSN: 0003-9926 Online ISSN: 1538-3652 Online ISSN: 1538-3660 Online ISSN: 1538-3679 NEW Print ISSN: 2168-6068 NEW Print ISSN: 2168-6076 NEW Print ISSN: 2168-6106 NEW Online ISSN: 2168-6084 NEW Online ISSN: 2168-6092 NEW Online ISSN: 2168-6114 Published By AMA Since: 1920 Published Since: 1999 Published Since: 1908 2016 Volume Number: 152 2016 Volume Number: 18 2016 Volume Number: 176 Description Description Description JAMA Dermatology publishes JAMA Facial Plastic Surgery is the JAMA Internal Medicine delivers peer-reviewed information concerning preeminent journal for all medical specialties high-impact, peer-reviewed advances a broad range of issues relating to the that perform cosmetic and reconstructive in internal medicine focusing on original skin and its conditions—clinical studies, surgery on the face, including facial plastic research, reviews, and controversies in surgical therapeutics, techniques, and surgery, dermatology, oculoplastic surgery, the field. Covering a broad range of topics, breakthrough treatments. maxillofacial surgery, and plastic surgery. the journal publishes essential information for informed decision making. It is the official publication for the Features Include American Academy of Facial Plastic and Features Include • Clinical Evidence Synopsis Reconstructive Surgery, the European • Clinicopathological Challenge Academy of Facial Plastic Surgery, and the • Original Investigations—Randomized trials, intervention studies, studies of International Federation of Facial Plastic • Patient Page screening and diagnostic tests, cohort Surgery Societies. 2014 Impact Factor studies, and cost-effectiveness studies covering diagnostic and therapeutic Features Include 4.6 (4.789 for 1 year of the previously advances, many accompanied by titled Archives of Dermatology and • Original Investigations Invited Commentaries 4.426 for 1 year of the newly titled JAMA • Surgical Pearl Videos • Less Is More—Cases in which less Dermatology), ranking first among clinical • Clinical Challenge health care results in better health, dermatology journals and fourth among with commentary on implications for all dermatology journals. 2014 Impact Factor clinical practice • Perspectives jamadermatology.com 1.4 (1.7 for 1 year of the previously titled Archives of Facial Plastic Surgery and 1.16 • Challenges in Clinical Electrocardiography for 1 year of the newly titled JAMA Facial 2014 Impact Factor Plastic Surgery). Journal Impact Factors may vary in the first few years following a 15.04 (17.333 for 1 year of the previously journal’s title change but are expected to titled Archives of Internal Medicine and match or exceed that of the previous title 13.116 for 1 year of the newly titled JAMA in subsequent years. Internal Medicine), ranking second among internal medicine journals and seventh jamafacialplasticsurgery.com among 153 general medical journals. jamainternalmedicine.com SPECIALTY JOURNALS Editor: Roger N. Rosenberg, MD Editor: Neil Bressler, MD Editor: Paul A. Levine, MD Print Frequency: 12 issues per year Print Frequency: 12 issues per year Print Frequency: 12 issues per year Print ISSN: 0003-9942 Print ISSN: 0003-9950 Print ISSN: 0886-4470 Online ISSN: 1538-3687 Online ISSN: 1538-3501 Online ISSN: 1538-361X NEW Print ISSN: 2168-6149 NEW Print ISSN: 2168-6165 NEW Print ISSN: 2168-6181 NEW Online ISSN: 2168-6157 NEW Online ISSN: 2168-6173 NEW Online ISSN: 2168-619X Published Since: 1959 Published By AMA Since: 1929 Published Since: 1925 2016 Volume Number: 73 2016 Volume Number: 134 2016 Volume Number: 142 Description Description Description JAMA Neurology provides an international JAMA Ophthalmology draws on JAMA Otolaryngology—Head & Neck perspective on a wide range of topics from academic, scientific, and clinical experts Surgery publishes clinical and basic leading centers of neurological research for a broad range of clinical and laboratory research from around the world on through peer-reviewed information, science articles, clinical trials, reviews, diseases of the head and neck. It is the forums, and features. commentaries, and a wide range of official publication for the American special features. Head and Neck Society and The Features Include American Academy of Facial Plastic • Clinical Trials—High-impact, Features Include and Reconstructive Surgery, Inc. peer-reviewed articles with direct • Clinical Trials Features Include clinical relevance • Journal Club • Original Investigations • Clinical Challenge • Clinical Challenge • Neurological Reviews • Clinical Challenge • Images in Neurology 2014 Impact Factor • Clinical Controversies in Otolaryngology 4.399 for 1 year of the previously titled • Author Interviews Archives of Ophthalmology and 3.318 2014 Impact Factor 2014 Impact Factor for 1 year of the newly titled JAMA 2.058 (2.327 for 1 year of the previously Ophthalmology. Journal Impact Factors titled Archives of Otolaryngology—Head & 7.348 (7.419 for 1 year of the previously may vary in the first few years following Neck Surgery and 1.794 for 1 year of the titled Archives of Neurology and 7.271 a journal’s title change but are expected newly titled JAMA Otolaryngology—Head for 1 year of the newly titled JAMA to match or exceed that of the previous & Neck Surgery). Neurology), ranking fourth among general title in subsequent years. neurology journals and tenth among all jamaotolaryngology.com 192 neurology
Load more

Recommended publications
  • 2021 Offerings Include
    JAMA 2021 Offerings Include: Print Edition Rate Card Effective January 1, 2021 • Patient Page Publication • Selections A supplement of curated articles on a therapeutic topic • Microsites Contact Account Manager for Information Contacts Editor Howard C. Bauchner, MD Boston University School of Medicine Insertion Order or Billing Questions Reprints Denise Steinhauser JAMA, JAMA Cardiology, JAMA Internal Medicine, (312) 464-2455 JAMA Ophthalmology, JAMA Neurology, JAMA Oncology, [email protected] JAMA Psychiatry and JAMA Network Open Marsha Fogler, Account Manager Production Questions JAMA Network Reprint Sales Michael Deegan [email protected] (312) 464-2401 USA: 1-800-482-1450 [email protected] Rest of World: 1-856-489-4446 Please include in the email the specific issue of JAMA in which your ad is running. (Note: JAMA is a weekly.) JAMA Dermatology, JAMA Otolaryngology-Head & Neck Surgery, JAMA Pediatrics, JAMA Surgery, and JAMA Network Open Display + Online Advertising Rachel Sisholtz Pharmaceutical | Device JAMA Network Reprint Sales (862) 261-9600 [email protected] Maureen Reichert USA: 1-800-482-1450 [email protected] Rest of World: 1-856-489-4446 (862) 261-9616 General Inquiries and Non-Profit Organization requests: Nancy Souza JAMA Network Reprints Communications [email protected] [email protected] (862) 261-9615 Requests from non-profit organizations, AMA members, medical Jeff Bonistalli societies, and academic institutions. Director of Advertising Pharmaceutical & Devices [email protected] Health Systems Branding | Products and Service | CME Recruitment Advertising (800) 262-2260 | (312) 464-5909 Fax [email protected] Thalia Moss [email protected] Anna Frazier Director of Advertising Health Systems & Recruitment [email protected] Domestic Subscription Rates (800) 262-2350 Online Site Licensing (312) 464-4371 Page 2 JAMA 2021 Print Edition Rate Card Rates 1.
    [Show full text]
  • The Journal Impact Factor Denominator Defining Citable (Counted) Items
    COMMENTARIES The Journal Impact Factor Denominator Defining Citable (Counted) Items Marie E. McVeigh, MS The items counted in the denominator of the impact fac- tor are identifiable in the Web of Science database by hav- Stephen J. Mann ing the index field document type set as “Article,” “Re- view,” or “Proceedings Paper” (a specialized subset of the VER ITS 30-YEAR HISTORY, THE JOURNAL IMPACT article document type). These document types identify the factor has been the subject of much discussion scholarly contribution of the journal to the literature and and debate.1 From its first release in 1975, bib- are counted as “citable items” in the denominator of the im- liometricians and library scientists discussed its pact factor. A journal accepted for coverage in the Thom- Ovalue and its vagaries. In the last decade, discussion has 6 son Reuters citation database is reviewed by experts who shifted to the way in which impact factor data are used. In consider the bibliographic and bibliometric characteristics an environment eager for objective measures of productiv- of all article types published by that journal (eg, items), which ity, relevance, and research value, the impact factor has been are covered by that journal in the context of other materi- applied broadly and indiscriminately.2,3 The impact factor als in the journal, the subject, and the database as a whole. has gone from being a measure of a journal’s citation influ- This journal-specific analysis identifies the journal sec- ence in the broader literature to a surrogate that assesses tions, subsections, or both that contain materials likely to the scholarly value of work published in that journal.
    [Show full text]
  • Web of Science Benefits
    Thomson.com Web of Science® What it offers. Why it matters to you. What Web of Science delivers How your work will benefit Content is the cornerstone For decades, the Thomson Scientific (formerly ISI) The result of this ongoing collection development? Excellence Editorial Development group has carefully Quality by default. without evaluated journals for potential inclusion in the excess database. Your search results will include only accurate, reliable, —— relevant data. You'll get not just more hits, but more The objective is to include only the most quality hits. You'll get the influential, relevant, and credible journal right answers, information available. If you publish — You'll easily find high impact quicker articles upon which to base your articles — increasing The criteria are detailed, unbiased, and time- the quality and credibility of your published work, tested — examining basic publishing standards, resulting in more publication in more prestigious timeliness, editorial scope and objectives, and sources. citation analyses. If you research — You'll be able to quickly identify The process is "publisher-neutral" — commercial, potential collaborators with prolific, significant citation open access, society, and university publishers are records. And tracking your own citation record will treated equally. help you demonstrate your work's impact on your field. Every publication indexed within Web of Science has passed through this rigorous evaluation If you teach — Your students will be assured of using process. the highest quality resources — finding valuable information in journals they may not have the knowledge and experience to seek on their own. It's a fact ... As of March 2006, the total number of Web of Science records is approximately 37 million.
    [Show full text]
  • Babes and Boobs? Analysis of JAMA Cover Art Jocalyn P Clark
    Papers BMJ: first published as 10.1136/bmj.319.7225.1603 on 18 December 1999. Downloaded from Babes and boobs? Analysis of JAMA cover art Jocalyn P Clark Abstract Of the 15 covers depicting women, 12 included Department of babies and six showed nudity. In contrast, only one Public Health Objective To determine the representation of the Sciences, University male image included a child and none contained of Toronto, Toronto, sexes in JAMA cover art. nudity. In the cover depicting a man with a child, the Canada M5S 1A8 doctoral candidate Design Review of 50 consecutive issues. man is not the child’s father but its doctor. Babes and Setting JAMA, March 1997-March 1998. boobs were featured in 12 of the 50 covers. Correspondence to: Main outcome measures Numbers and nature of J P Clark, Centre for Research in covers portraying men and women. Women’s Health, Results Of the 50 covers, 34 depicted humans. 15 Conclusions Toronto, Canada depicted women, 13 men, and 6 were of mixed or M5G 1N8 Visual imagery associated with medical journals shapes [email protected] indeterminate sex. 11 pictures of women included a our understanding of health and the human body. child and five included nudity. One cover showed a Images of babes and boobs in cover art emphasise BMJ 1999;319:1603–5 man with a child (not as a father) and none depicted women’s sexual and domestic roles, representing nudity. Men were depicted exclusively in authoritative women in traditional and stereotypical ways that under- roles. mine contemporary beliefs in the equality, autonomy, Conclusions Much of the cover art gives strong and status of women.34 These representations do not messages about sexual stereotypes that are reflect women’s contributions to the domains of science, inappropriate in modern society.
    [Show full text]
  • Affidavit of Stephen Barrett, M.D
    IN THE IOWA DISTRICT COURT FOR POLK COUNTY ________________________________________________________________ _ STATE OF IOWA ex rel. ) THOMAS J. MILLER, ) ATTORNEY GENERAL OF IOWA, ) EQUITY NO. CE-39318 99AG25112 ) ) Plaintiff , ) ) vs. ) AFFIDAVIT OF DR. ) STEPHEN BARRETT NEW WOMYN, INC. and ) DAN KAISER, ) ) Defendants. ) ________________________________________________________________ _ 1. I, Dr. Stephen Barrett of Allentown, Pennsylvania, being first duly sworn on oath, depose and state as follows: 2. I submit this declaration as an expert in the fields of quackery, “alternative medicine,” health fraud, peer review, and the analysis of unusual health claims. I intend this declaration to serve as expert testimony on the matters set forth herein. All opinions rendered herein are my professional and expert opinion, as consistent with my special knowledge, skill, training, education, and experience. 3. I have been asked by Investigator Barbara Blake of the Consumer Protection Division of the Iowa Department of Justice to review Paragraph 9 (a)-(d) of the Petition and Application to Enforce Civil Investigative Demand filed in the above-captioned matter. I have been asked to assume that the alleged representations as set forth below were made for a device called - 1 - "Stimulations VII" that was to be used by persons to enhance breast size. I have been further asked to express an opinion regarding the amount of substantiation experts in the field would agree is reasonable for the types of claims set forth below. 4. The claims set forth in the Petition are: (a). That Stimulations VII will permanently grow breast tissue; (b.) That Stimulations VII will cause breast enlargement of 2, 3 or even 4 cup sizes; (c.) That Stimulations VII has been scientifically proven safe and effective for breast enlargement; (d.) That Stimulations VII will regrow breasts that have been removed via mastectomy.
    [Show full text]
  • Thank You to JAMA Peer Reviewers, Authors, and Readers Phil B
    Opinion Editorials represent the opinions of the authors and JAMA EDITORIAL and not those of the American Medical Association. Thank You to JAMA Peer Reviewers, Authors, and Readers Phil B. Fontanarosa, MD, MBA; Howard Bauchner, MD In this issue of JAMA, we are pleased to publish the names of the Table. JAMA Statistics for 2013 3960 peer reviewers of JAMA manuscripts in 2013.1 We extend our sincere thanks to these reviewers for their thoughtful, insightful, Manuscript Data No. Major manuscripts received 6937 and scholarly evaluation of manuscripts. Even though the peer Research manuscripts received 4731 review process continues to undergo evaluation and evolution,2 Acceptance rate (overall), % 9 we find the comments and suggestions from JAMA peer review- Acceptance rate (research), % 4 ers an indispensable aspect of the scientific publication process. Manuscripts sent for external review, % 30 We also extend our sincere thanks to all authors who sub- Peer reviewers 3960 mitted manuscripts for consideration for publication in JAMA. Peer reviewer turnaround, median, d 13 In 2013, the 6937 total manuscripts and 4731 research papers Receipt to rejection, median, da 6 a submitted, as well as the 78 randomized clinical trials, Receipt to acceptance, median, d 27 Acceptance to publication, median, da 32 124 Editorials, and 192 View- Receipt to publication, median, da 77 points published in JAMA, Related article 742 Clinical trials published 78 represent all-time highs Impact factor (2012 data) 30 (Table and eTable in the Information Dissemination
    [Show full text]
  • National Citation Patterns of NEJM, the Lancet, JAMA and the BMJ in the Lay Press: a Quantitative Content Analysis
    Open Access Research BMJ Open: first published as 10.1136/bmjopen-2017-018705 on 12 November 2017. Downloaded from National citation patterns of NEJM, The Lancet, JAMA and The BMJ in the lay press: a quantitative content analysis Gonzalo Casino,1 Roser Rius,2 Erik Cobo2 To cite: Casino G, Rius R, ABSTRACT Strengths and limitations of this study Cobo E. National citation Objectives To analyse the total number of newspaper patterns of NEJM, The Lancet, articles citing the four leading general medical journals ► This is the first study that analyses the citations of JAMA and The BMJ in the and to describe national citation patterns. lay press: a quantitative the four leading general medical journals in the lay Design Quantitative content analysis. content analysis. BMJ Open press. Setting/sample Full text of 22 general newspapers in 2017;0:e018705. doi:10.1136/ ► This study shows the existence of a national factor 14 countries over the period 2008–2015, collected from bmjopen-2017-018705 in science communication that needs to be further LexisNexis. The 14 countries have been categorised into monitored and analysed. ► Prepublication history for four regions: the USA, the UK, Western World (European ► Citation and correspondence analyses offer a new this paper is available online. countries other than the UK, and Australia, New Zealand To view these files, please visit way to quantify and monitor the media impact of and Canada) and Rest of the World (other countries). the journal online (http:// dx. doi. scientific journals. Main outcome measure Press citations of four medical org/ 10. 1136/ bmjopen- 2017- ► This study is observational and descriptive; thus, it journals (two American: NEJM and JAMA; and two British: 018705).
    [Show full text]
  • Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19): a Review
    Clinical Review & Education JAMA | Review Pharmacologic Treatments for Coronavirus Disease 2019 (COVID-19) A Review James M. Sanders, PhD, PharmD; Marguerite L. Monogue, PharmD; Tomasz Z. Jodlowski, PharmD; James B. Cutrell, MD Viewpoint pages 1769, and IMPORTANCE The pandemic of coronavirus disease 2019 (COVID-19) caused by the novel 1767 severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) presents an unprecedented Related article page 1839 challenge to identify effective drugs for prevention and treatment. Given the rapid pace of CME Quiz at scientific discovery and clinical data generated by the large number of people rapidly infected jamacmelookup.com by SARS-CoV-2, clinicians need accurate evidence regarding effective medical treatments for this infection. OBSERVATIONS No proven effective therapies for this virus currently exist. The rapidly Author Affiliations: Department of expanding knowledge regarding SARS-CoV-2 virology provides a significant number of Pharmacy, University of Texas potential drug targets. The most promising therapy is remdesivir. Remdesivir has potent in Southwestern Medical Center, Dallas vitro activity against SARS-CoV-2, but it is not US Food and Drug Administration approved (Sanders, Monogue); Division of Infectious Diseases and Geographic and currently is being tested in ongoing randomized trials. Oseltamivir has not been shown to Medicine, Department of Medicine, have efficacy, and corticosteroids are currently not recommended. Current clinical evidence University of Texas Southwestern does not support stopping angiotensin-converting enzyme inhibitors or angiotensin receptor Medical Center, Dallas (Sanders, Monogue, Cutrell); Pharmacy Service, blockers in patients with COVID-19. VA North Texas Health Care System, Dallas (Jodlowski). CONCLUSIONS AND RELEVANCE The COVID-19 pandemic represents the greatest global public health crisis of this generation and, potentially, since the pandemic Corresponding Author: James B.
    [Show full text]
  • Omega-3 Supplements May Interact with Drugs That Affect Blood Clotting
    U.S. Department of Health & Human Services National Institutes of Health Omega-3 Supplements © Zoonar/Thinkstock Omega-3 fatty acids (omega-3s) are a group of polyunsaturated fatty acids that are important for a number of functions in the body. Some types of omega-3s are found in foods such as fatty fish and shellfish. Another type is found in some vegetable oils. Omega-3s are also available as dietary supplements. This fact sheet provides basic information about omega-3s—with a focus on dietary supplements, summarizes scientific research on effectiveness and safety, and suggests sources for additional information. Key Facts — There has been a substantial amount of research on supplements of omega-3s, particularly the types of omega-3s found in seafood and fish oil, and heart disease. The findings of individual studies have been inconsistent. In 2012, two combined analyses of the results of these studies did not find convincing evidence that these omega-3s protect against heart disease. — There is some evidence that omega-3s of the types found in seafood and fish oil may be modestly helpful in relieving symptoms in rheumatoid arthritis. For most other conditions for which omega-3s have been studied, definitive conclusions cannot yet be reached, or studies have not shown omega-3s to be beneficial. — Omega-3 supplements may interact with drugs that affect blood clotting. — It is uncertain whether people with fish or shellfish allergies can safely consume fish oil supplements. — Fish liver oils (which are not the same as fish oils) contain vitamins A and D as well as omega-3 fatty acids; these vitamins can be toxic in high doses.
    [Show full text]
  • JAMA Oncology—The Year in Review, 2019 Mary L
    Opinion EDITORIAL JAMA Oncology—The Year in Review, 2019 Mary L. (Nora) Disis, MD JAMA Oncology had a very active year in 2019. The journal’s receive the JAMA Oncology electronic table of contents by impact factor of 22.4 places it as one of the highest-ranking email, you can sign up at http://www.jamaoncology.com.We oncology journals. I thank our authors, peer reviewers, and are proud to continue offering the most innovative, provoca- readers for the significant contributions made to the journal tive, and timely research for scientists, clinicians, and train- this past year. The editorial ees in the field of oncology worldwide. I encourage readers Related article board, our JAMA Oncology to stay involved with the journal by submitting Letters to the editors, and I are honored to Editor and offering recommendations for new topics that have the opportunity to serve the oncology community by you would like to see covered in future issues. Your sugges- offering original, innovative, and timely scientific content tions make this interdisciplinary oncology journal dynamic that has a direct impact on researchers, clinicians, and the and current. patients we serve. We have truly enjoyed being involved in JAMA Oncology’s Choosing manuscripts for the journal was rewarding continued success this year and look forward to the year ahead. but challenging. We received a total of 2980 manuscript sub- We could not have done it without you. I invite all of our missions in 2019. These submissions to JAMA Oncology readers to follow us on Twitter @JAMAOnc or friend JAMA included 1743 Original Investigations, 66 Clinical Trial Oncology on Facebook.
    [Show full text]
  • MEDICAL JOURNALS Because They ’S Web Site At
    JAMA PATIENT PAGE The Journal of the American Medical Association MEDICAL JOURNALS Medical Journals edical journals are publications that report medical information to physicians and other health professionals. In the past, these journals were available only in print. With the development of electronic publishing, many Mmedical journals now have Web sites on the Internet, and some journals publish only online. A few medical journals, like the Journal of the American Medical Association (JAMA), are considered general medical journals because they cover many fields of medicine. Most medical journals are specialty journals that focus on a particular area of medicine. The June 5, 2002, issue of JAMA is dedicated to articles about medical journals. TYPES OF ARTICLES Medical journals publish many types of articles. Research articles report the results of research studies on a range of topics varying from the basic mechanisms of diseases to clinical trials that compare outcomes of different treatments. Research articles on important topics may be covered by the news media when they are published in a medical journal. Review articles summarize and analyze the information available on a specific topic based on a careful search of the medical literature. Because the results of individual research studies can be affected by many factors, combining results from different studies on the same topic can be helpful in reaching conclusions about the scientific evidence for preventing, diagnosing, or treating a particular disease. Case conferences and case reports may be published in medical journals to educate physicians about particular illnesses and how to treat them. Editorials in medical journals are short essays that express the views of the authors, often regarding a research or review article published in the same issue.
    [Show full text]
  • Data Sharing Statements for Clinical Trials a Requirement of the International Committee of Medical Journal Editors Darren B
    Opinion EDITORIAL Data Sharing Statements for Clinical Trials A Requirement of the International Committee of Medical Journal Editors Darren B. Taichman, MD, PhD; Peush Sahni, MB, BS, MS, PhD; Anja Pinborg, MD; Larry Peiperl, MD; Christine Laine, MD, MPH; Astrid James, MB, BS; Sung-Tae Hong, MD, PhD; Abraham Haileamlak, MD; Laragh Gollogly, MD, MPH; Fiona Godlee, FRCP; Frank A. Frizelle, MB, ChB, FRACS; Fernando Florenzano, MD; Jeffrey M. Drazen, MD; Howard Bauchner, MD; Christopher Baethge, MD; Joyce Backus, MSLS The International Committee of Medical Journal Editors (ICMJE) nisms are not in place to mandate universal data sharing at this believes there is an ethical obligation to responsibly share data time. Although many issues must be addressed for data shar- generated by interventional clinical trials because trial partici- ing to become the norm, we remain committed to this goal. pants have put themselves at risk. In January 2016 we pub- Therefore, ICMJE will require the following as conditions lished a proposal aimed at helping to create an environment in of consideration for publication of a clinical trial report in our which the sharing of deidentified individual participant data member journals: becomes the norm. In response to our request for feedback we 1. As of July 1, 2018, manuscripts submitted to ICMJE jour- received many comments from individuals and groups.1 Some nals that report the results of clinical trials must contain a applauded the proposal while others expressed disappoint- data sharing statement as described below. ment it did not more quickly create a commitment to data shar- 2. Clinical trials that begin enrolling participants on or after Janu- ing.
    [Show full text]